Elsevier

Matrix Biology

Volume 24, Issue 4, June 2005, Pages 261-270
Matrix Biology

Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: Implications for collagen cross-linking and treatment of fibrosis

https://doi.org/10.1016/j.matbio.2005.04.002Get rights and content

Abstract

Collagen deposits in fibrotic lesions often display elevated levels of hydroxyallysine (pyridinoline) cross-links. The relation between the occurrence of pyridinoline cross-links and the irreversibility of fibrosis suggests that these cross-links contribute to the aberrant accumulation of collagen. Based on its inhibitory effect on lysyl hydroxylase activity minoxidil has been postulated to possess anti-fibrotic properties by limiting the hydroxylysine supply for hydroxyallysine cross-linking. However, to interfere with hydroxyallysine cross-linking specifically lysyl hydroxylation of the collagen telopeptide should be inhibited, a reaction predominantly catalysed by lysyl hydroxylase (LH) 2b. In this study, we demonstrate that minoxidil treatment of cultured fibroblasts reduces LH1>>LH2b>LH3 mRNA levels dose-and time-dependently, but has essentially no effect on the total number of pyridinoline cross-links in the collagen matrix. Still the collagen produced in the presence of minoxidil displays some remarkable features: hydroxylation of triple helical lysine residues is reduced to 50% and lysylpyridinoline cross-linking is increased at the expense of hydroxylysylpyridinoline cross-linking. These observations can be explained by our finding that LH1 mRNA levels are the most sensitive to minoxidil treatment, corroborating that LH1 has a preference for triple helical lysine residues as substrate. In addition, the non-proportional increase in cross-links (20-fold) with respect to the decrease in lysyl hydroxylation state of the triple helix (2-fold) even suggests that LH1 preferentially hydroxylates triple helical lysine residues at the cross-link positions. We conclude that minoxidil is unlikely to serve as an anti-fibroticum, but confers features to the collagen matrix, which provide insight into the substrate specificity of LH1.

Introduction

The synthesis of collagen is a multi-step process, involving several unique post-translational modifications essential for the stabilisation of the collagen molecule. The assembly of collagen molecules into the functional unit, the collagen fibril, is further stabilised by covalent intermolecular cross-links. Hydroxylation of lysine residues is one of the key steps in the maturation of collagen, providing specific sites for glycosylation (Kadler, 1994) and determining the chemical nature of the intermolecular cross-links (Eyre, 1987). A family of lysyl hydroxylases (LH; EC 1.14.11.4), consisting of LH1, LH2a, LH2b, and LH3, is responsible for the catalytic conversion of lysine into hydroxylysine (Hautala et al., 1992a, Pasquali et al., 1997, Passoja et al., 1998, Risteli et al., 2004, Valtavaara et al., 1997, Valtavaara et al., 1998, Yeowell and Walker, 1999). Mutations in LH1 lead to the clinical phenotype of Ehlers–Danlos syndrome type VI (EDS VI; OMIM#225400) (Yeowell and Walker, 2000), which is biochemically characterised by a deficiency in triple helical hydroxylysine residues (Steinmann et al., 1995). An almost complete lack of hydroxylated lysine residues in the collagen telopeptides is seen in Bruck syndrome (BS; OMIM#259450) bone (Bank et al., 1999) and in a number of BS patients LH2 is mutated (Ha-Vinh et al., 2004, van der Slot et al., 2003). These connective tissue disorders indicate substrate specificity for the different lysyl hydroxylases and their clinical phenotypes show the devastating effect of disturbed hydroxylation of triple helical or telopeptide lysine residues on tissue performance. The specificity of LH1 is likely directed towards the lysine residues in the helical domain of the collagen molecule (Pasquali et al., 1997). There is a growing body of evidence that LH2b is involved in the hydroxylation of telopeptide lysine residues (Mercer et al., 2003, Pornprasertsuk et al., 2004, Uzawa et al., 1999, van der Slot et al., 2003, van der Slot et al., 2004). No mutations in LH3 have been identified so far that can be linked to a disorder of the extracellular matrix and its lysyl substrate specificity is as yet unknown. LH3 is different from the other two lysyl hydroxylases in that it also displays glucosyl and galactosyl transferase activity, thereby contributing to the glycosylation of hydroxylysine residues in the collagen molecule (Heikkinen et al., 2000, Wang et al., 2002). The embryonic lethality of LH3 knock-out mice shows that this lysyl hydroxylase provides essential functions in the body (Rautavuoma et al., 2004).

The hydroxylation status of the cross-linking residue in the collagen telopeptide, being either lysine or hydroxylysine, determines the route of intermolecular enzymatic cross-linking. In the allysine cross-linking route lysine is converted by lysyl oxidase (LOX) into the aldehyde allysine, whereas in the hydroxyallysine route hydroxylysine is converted into the aldehyde hydroxyallysine. These aldehydes further react with a lysine, hydroxylysine, or histidine in the triple helix to form di-, tri-, or tetra-functional cross-links (Eyre et al., 1984b, Reiser et al., 1992, Robins, 1982). The mature cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) are formed via the hydroxyallysine route and differ only with respect to the triple helical residue involved in the cross-link, hydroxylysine and lysine, respectively (Eyre, 1987). These kinds of cross-links occur in a variety of connective tissues such as bone, cartilage, tendon, and ligaments. In contrast, skin collagen contains predominantly allysine-derived cross-links and only minor amounts of hydroxyallysine-derived cross-links (Eyre et al., 1984a). In general, the prevalence of a certain type of cross-link appears to be tissue-specific and is involved in providing tissues with certain properties (Banse et al., 2002, Wassen et al., 2000).

In fibrotic disorders, which are characterised by an accumulation of collagen, an increase in hydroxyallysine cross-linking is observed (Bailey et al., 1975, Brenner et al., 2000, Istok et al., 2001, Last et al., 1990, Ricard-Blum et al., 1992). There are strong indications that these cross-links diminish the susceptibility of collagen to proteolytic degradation and in this way contribute to the unwanted collagen accumulation in fibrosis (Bailey et al., 1975, Bailey and Light, 1985, Last et al., 1990, Ricard-Blum et al., 1992, Ricard-Blum et al., 1993). It is therefore plausible that redirecting collagen cross-linking towards the allysine route, by reducing the overhydroxylation of telopeptide lysine residues, prevents the irreversible deposition of collagen. We have previously shown that an elevated LH2b expression in fibrotic cells is associated with an increase in pyridinoline cross-links in the collagen deposited by these cells. These data indicate that induction of LH2b expression leads to overhydroxylation of telopeptide lysine residues and the concomitant formation of hydroxyallysine cross-links (van der Slot et al., 2003, van der Slot et al., 2004). Consequently, LH2b becomes a prime target for an anti-fibrosis therapy based on decreasing hydroxyallysine cross-linking.

Minoxidil, an antihypertensive drug, has been reported to reduce lysyl hydroxylase activity by decreasing the LH1 mRNA level (Hautala et al., 1992b, Murad and Pinnell, 1987, Pinnell and Murad, 1987). At the time these studies were performed it was not known that different isoforms of lysyl hydroxylase existed, but it was already postulated that minoxidil would have anti-fibrotic properties by limiting the supply of hydroxylysines for hydroxyallysine cross-link formation (Murad et al., 1994). In the present study we investigated the effect of minoxidil on the gene expression of each individual lysyl hydroxylase, in particular LH2b, and on the cross-linking of collagen to examine whether minoxidil indeed has the potential to decrease hydroxyallysine cross-link formation.

Section snippets

Inhibiting properties of minoxidil on LH gene expression

To unravel the effect of minoxidil on gene expression of the different lysyl hydroxylases, dose- and time-dependent responses were examined in fibroblasts derived from subcutaneous fat of one donor. These fibroblasts were used because of their elevated levels of LH2b gene expression and hydroxyallysine cross-links compared to fibroblasts isolated from dermis (Van Den Bogaerdt, 2004). Concentration-dependent effects on the mRNA levels of LH1, LH2b, and LH3 after a 24 h incubation period were

Discussion

Collagen deposition in human fibrotic tissues often displays an increase in hydroxyallysine-derived cross-links (van der Slot et al., 2004), which most likely contributes to the unwanted accumulation of collagen by conferring increased resistance to proteolytic degradation (Bailey et al., 1975, Bailey and Light, 1985, Last et al., 1990, Ricard-Blum et al., 1992, Ricard-Blum et al., 1993). After the discovery of the inhibitory action on lysyl hydroxylase gene expression, minoxidil was postulated

Fibroblast cultures

Primary fibroblasts obtained from healthy dermis, subcutaneous fat, and keloid were isolated as described in Van Den Bogaerdt et al., 2002. Primary fibroblasts of one keloid donor were obtained from the American Type Culture Collection (ATCC; CRL-1762). Cells were cultured in Dulbecco's Modified Eagles Medium (DMEM; BioWhittaker) containing ultraglutamine I and supplemented with 10% heat-inactivated fetal calf serum (FCS), 100 U/ml penicillin and 100 U/ml streptomycin at 37 °C in 5% CO2. Upon

Acknowledgements

We would like to thank Dr. E. Middelkoop from the Association of Dutch Burn Centers (Beverwijk, The Netherlands) for providing split skin- and subcutaneous fat-derived fibroblasts. This study was supported by the Dutch Arthritis Association Grant 99-2-201, the Netherlands Organization for Scientific Research (NWO) Grant 902-27-222, and the Dutch Burns Foundation Grant WO/P04.101.

References (55)

  • L. Knott et al.

    Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance

    Bone

    (1998)
  • D.K. Mercer et al.

    Identification, expression, and tissue distribution of the three rat lysyl hydroxylase isoforms

    Biochem. Biophys. Res. Commun.

    (2003)
  • S. Murad et al.

    Suppression of fibroblast proliferation and lysyl hydroxylase activity by minoxidil

    J. Biol. Chem.

    (1987)
  • S. Murad et al.

    Structure–activity relationship of minoxidil analogs as inhibitors of lysyl hydroxylase in cultured fibroblasts

    Arch. Biochem. Biophys.

    (1992)
  • S. Murad et al.

    Minimum structural requirements for minoxidil inhibition of lysyl hydroxylase in cultured fibroblasts

    Arch. Biochem. Biophys.

    (1994)
  • V.H. Rao et al.

    Decreased thermal denaturation temperature of osteogenesis imperfecta mutant collagen is independent of post-translational overmodifications of lysine and hydroxylysine

    J. Biol. Chem.

    (1989)
  • M. Risteli et al.

    Characterization of collagenous peptides bound to lysyl hydroxylase isoforms

    J. Biol. Chem.

    (2004)
  • S. Tajima et al.

    A comparison of lysyl hydroxylation in various types of collagen from type VI Ehlers–Danlos syndrome fibroblasts

    Coll. Relat. Res.

    (1983)
  • K. Uzawa et al.

    Lysine hydroxylation of collagen in a fibroblast cell culture system

    Biochem. Biophys. Res. Commun.

    (2003)
  • M. Valtavaara et al.

    Cloning and characterization of a novel human lysyl hydroxylase isoform highly expressed in pancreas and muscle

    J. Biol. Chem.

    (1997)
  • M. Valtavaara et al.

    Primary structure, tissue distribution, and chromosomal localization of a novel isoform of lysyl hydroxylase (lysyl hydroxylase 3)

    J. Biol. Chem.

    (1998)
  • A.J. van der Slot et al.

    Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis

    J. Biol. Chem.

    (2003)
  • A.J. van der Slot et al.

    Increased formation of pyridinoline cross links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon

    Matrix Biol.

    (2004)
  • C. Wang et al.

    The third activity for lysyl hydroxylase 3: galactosylation of hydroxylysyl residues in collagens in vitro

    Matrix Biol.

    (2002)
  • H.N. Yeowell et al.

    Tissue specificity of a new splice form of the human lysyl hydroxylase 2 gene

    Matrix Biol.

    (1999)
  • H.N. Yeowell et al.

    Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers–Danlos syndrome type VI

    Mol. Genet. Metab.

    (2000)
  • H.N. Yeowell et al.

    Characterization of a partial cDNA for lysyl hydroxylase from human skin fibroblasts; lysyl hydroxylase mRNAs are regulated differently by minoxidil derivatives and hydralazine

    J. Invest. Dermatol.

    (1992)
  • Cited by (41)

    • Lysyl hydroxylase 2 deficiency promotes filopodia formation and fibroblast migration

      2022, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      The importance of lysyl hydroxylation is highlighted by the role of LH1-3 deficiencies in inheritable disorders, such as Ehlers-Danlos syndrome type VI, Bruck syndrome, and Epidermolysis bullosa-like syndromes, respectively [4]. LH2 expression is universally up-regulated in fibrosis [5–7]. LH2-mediated hydroxylation of telopeptidyl lysine residues in collagen initiates formation of hydroxylysine aldehyde-derived collagen cross-links (HLCCs), which are highly stable and resistant to cleavage by collagenases [5,6,8–11].

    • Current and upcoming therapies to modulate skin scarring and fibrosis

      2019, Advanced Drug Delivery Reviews
      Citation Excerpt :

      Interestingly, depending on their specificity, PHI can cross-react with the prolyl hydroxylase that modifies the angiogenic transcription factor hypoxia induce factor-α, thus potentially inducing angiogenesis and preventing scar formation [167,168]. Hydroxylation of lysine residues is another essential step for the proper cross-linking and glycosylation of α-chains leading to the formation of functional collagen proteins [169,170]. Like prolyl hydroxylases, these affect collagen in its pro-peptide stage, requiring the same co-factors to function [137].

    • PLOD2 in cancer research

      2017, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      Thus far, several pharmacologic inhibitors have been confirmed to have an anti-metastasis effect, whereas some compounds may be candidate inhibitors. Minoxidil is the only inhibitor of PLOD2 that has been fully confirmed by previous reports [7,47,48]. Interestingly, reports show that minoxidil could suppress the expression of PLOD2, inhibit the cancer migration, and reverse the collagen cross-link switch, resulting in the anti-metastasis effect in vitro and in vivo [7,47].

    • Essential roles of insulin, AMPK signaling and lysyl and prolyl hydroxylases in the biosynthesis and multimerization of adiponectin

      2015, Molecular and Cellular Endocrinology
      Citation Excerpt :

      Minoxidil (1000 µM) reportedly suppresses levels of LH mRNAs in fibroblasts (Zuurmond et al., 2005), its most profound effect being on LH1 expression. It can almost completely inhibit LH1 mRNA levels: however it affects the mRNA levels of LH2b and LH3 to a much lesser extent, to ~35% of control values (Zuurmond et al., 2005). However, our results showed that, in fully-differentiated 3T3-L1 adipocytes, minoxidil at 1000 µM exerted a suppressive effect on the mRNA expression levels of LHs to the extent that Plod1was reduced to ~50% of control value, Plod2a and Plod3 to ~75%, whereas Plod2b was unchanged.

    View all citing articles on Scopus
    View full text